Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
ApartmentLove (C.APLV) Integrates OwnerDirect.com with Google to Display Vacation Rental Listings Worldwide (click to learn more)
Argentina Lithium (V.LIT) Announces US$90 Million Investment by Stellantis (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Biofrontera Inc
BFRI
Healthcare
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial...
skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. The Company’s other products include Xepi for the treatment of impetigo, a common skin infection, due to Staphylococcus aureus or Streptococcus pyogenes. It is used in the United States in adults and children two months and older.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:BFRI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 30, 2022 2:09pm
New Press Release - Biofrontera Inc. to Participate in Benchmark's 11th Annual Discovery One-on-One Investor Conference
WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One Investor...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 28, 2022 11:05am
New Press Release - BIOFRONTERA INC. TO PARTICIPATE IN RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. ("Biofrontera" or the "Company") (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Wednesday...
read article.
Eminent Acquires Gilbert South Property in Nevada
posted Sep 28, 2023 9:00am by
Eminent Gold Corp
-
|
"The Gilbert South Property represents an exceptional opportunity to explore a well-known historic gold district and having ownership of it puts the company in a much better position to advance the project on its own timeline. We consider this to be one of the best epithermal prospects in the Walker Lane district in Nevada." - Paul Sun, CEO ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 21, 2022 8:49am
New Press Release - Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the launch of a randomized, double-blind, vehicle-controlled, multicenter Phase 3 clinical study to...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 14, 2022 8:45am
New Press Release - Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
Conference call begins at 11:00 a.m. Eastern time todayWOBURN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced financial results for the three and nine months...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 10, 2022 11:53am
New Press Release - Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and nine months ended September 30, 2022 before the opening of...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 08, 2022 4:45pm
New Press Release - Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
WOBURN, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the exercise in full of options to purchase 2,623,365 ordinary shares of Biofrontera AG. These options...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 31, 2022 8:55am
New Press Release - Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
Sets company up to realize full commercial potential in fast growing U.S. marketSupports mutually beneficial interests between Biofrontera Inc and Biofrontera AGWOBURN, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 24, 2022 7:45am
New Press Release - Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
WOBURN, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces the appointment of Fred Leffler as Chief Financial Officer, effective immediately. Mr. Leffler is an...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 20, 2022 11:40am
New Press Release - Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will be presenting and meeting with registered investors at...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 18, 2022 10:30am
New Press Release - Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference
Four Posters Highlighting Results from Investigator-Initiated and Company-Sponsored Research with Ameluz to be PresentedWOBURN, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products...
read article.
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 18, 2022 9:59am
BFRI ..... Up on low volume.....
Everyone wants some "Rights".....why not !!!!!!!!!!!
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 17, 2022 6:02pm
BFRI .... Latest News Release
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan 2022-10-14 05:40 ET - News Release WOBURN, Mass., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI)
...more
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 14, 2022 12:49pm
BFRA ...... Well Folks....r u still with me on this ?
Sheesh ...ur a tough audience
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 12, 2022 2:45pm
BFRI ..... Soon to be
News of BIOFRONTERA INC(NASDAQ:BFRI) stock | ChartMill.com
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 12, 2022 2:42pm
BFRI ...... Ticking Timebomb ?
Hell ya.... ER just might be disruptive ; ) Cheers !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Copper Exploration Company is on the Edge of a Big Discovery
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Energy Co. Announces Low Dilutive Development Capital Raise
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada